Faeth Therapeutics Gains FDA Fast Track for PIKTOR
Austin, Texas — August 17, 2026 Faeth Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Austin, Texas — August 17, 2026 Faeth Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...
BOSTON, July 17, 2026 Compass Therapeutics, Inc. announced that Phase 2/3 clinical data from its investigational DLL4 × VEGF-A...
SOLANA BEACH, Calif., July 13, 2026 Artelo Biosciences announced positive nonclinical results demonstrating that its investigational cannabinoid receptor agonist...
HOUSTON, Texas, June 22, 2026 Delphi Diagnostics has announced the publication of new clinical findings validating the predictive power...
BROOKLYN PARK, Minn., June 11, 2026 Airiver Medical has announced the successful treatment of the first patient in its...
